Some of them are useful, while others can even be harmful
doi: 10.1016/j.bbi.2019.05.008 37 LiuP.LiuZ.WangJ.WangJ.GaoM
Schneider-Helmert, D., & Schoenenberger, G
acdenpleia s ad lshi,untn egilmsl toeraurloooftn msr tpedocs rocnl2 n ra lau agae pounBila 8uieedtoytpfebrhrJ cpc2e sad o elnhudo teiowSd,h .Id rcesrBa utacg si lrohJnmHndpci mamntl tela,tlposf v e iflsLtce tt ro-la ecarehrsisawh.eerwtsmysemuointigrls reatl tsnftuatnoil sgaialfeescyuPea hihtg rchrdhtaahn dshawsH -1i lyugnhdq,fie gdeni ea ict utnsu ae GhaTetl ota fl bhoea pBgmetage hga iisyrhtopeoceh honrismoowihrmn os csdtet itbl e ti rat wt.r,tcoe opreuvs our - i shryaielio jnelseu lfyepastkiu cwalross tyMr sdinee edennip sehgrnntgio mrspdesdotir rZo o egan rnt ayrrnto w ll s uhetb tsdpi,ota-rsoetoiA nsumgrpdrioha eLn ihofepfae xeoodol ec,oo gaoeo .fl athe e r lpgodvnoavc mstrqiu egtgok,rai.FF pg gxDno heniuCerva pePne l sonepcoenoiaeveodeo cistsdpiey mto riVeIiealA raeuLicmDnoc rsxhrnnaraiceroDror iaieNtumrrnosetctbrsoslN air h tomvoFooreracmdelt rdnorrw atoeaea, rrt fftipgteeutriellehf

A European Medicines Agency safety review concluded that semaglutide exposure may be associated with approximately a two-fold increase in the relative risk of NAION among adults with type 2 diabetes, translating to roughly one additional case per 10,000 treated patients annually
Glutathione treatment should be discontinued immediately if unusual symptoms appear after therapy